Program

Download Program PDF

Thursday 22 July

Timing	Session	Speaker / Comments
8:30 - 10:00	Registrations Exhibition booths open at 8:30am	Light refreshments will be served
10:00 - 10:10	Welcome	Dr Emily Stone ASM2021 Conference Convenor
10:10 - 10:25	Opening Address	Alexandra Golledge
10:25 - 10:55	Plenary Session	The Taiwan Lung Cancer Screening in Never-Smoker Trial (TALENT) Chair: Dr Emily Stone Prof Pan Chyr Yang Department of Internal Medicine and Dean of the National Taiwan University College of Medicine, Taiwan
10:55 - 11:20	Keynote Address	Neoadjuvant treatment options in early-stage disease Chair: Mr Phillip Antippa A/Prof Jay Lee Division of Thoracic Surgery, UCLA Santa Monica Medical Center, United States
11:20 - 11:45	Keynote Address	The potential of proteogenomics to identify lung cancer treatment pathways Chair: Prof Nick Pavlakis Professor Ramaswamy Govindan Department of Medicine, Oncology Division, Washington University School of Medicine, St. Louis, Missouri, United States
11:45 - 12:05	Panel	Panel: Prof Ramaswamy Govindan, A/Prof Jay Lee, Prof Nick Pavlakis, Prof Wendy Cooper, Mr Phillip Antippa,Dr Emily Stone
12:05 - 13:00	Lunch
13:00 - 13:30	Keynote Address	Stereotactic Ablative Body Radiotherapy (SABR) for oligometastatic lung cancer Chair: A/Prof Shalini Vinod Speaker: A/Prof Shankar Siva Lead, Stereotactic Ablative Body Radiotherapy (SABR) program, Peter MacCallum Cancer Centre, Melbourne, Australia
13:30 - 15:15	Oral Abstracts Session	Chair: Dr Rachel Roberts-Thomson Systematic Review of Neoadjuvant Immunotherapy for Patients with Resectable Non-Small Cell Lung Cancer- Dr Christopher Cao Acceptability and Feasibility of Lung Cancer Screening in Australia- Dr Rachael Dodd Treatment burden experienced by patients with lung cancer- Nicole El-Turk The expression and clinical relevance of Schlafen-11 and MGMT as a combined biomarker in patients with malignant pleural mesothelioma- Dr Helen Ke A systematic review into the radiological features predicting local recurrence after SABR in patients with NSCLC- Dr Katherine Lee Generalisability of Phase III Immunotherapy Trials in Advanced Lung Cancer to Real-World Patients- Dr Monica Tang Emphysema as a ‘Radiomic-Biomarker’ Using Low-Dose Computed Tomography Scans in High-Risk Smokers in an Australian Cohort- Dr Katrina Tonga
15:15 - 15:45	Afternoon Tea
15:45 - 17:00	Updates in Precision Medicine	Chair: Prof Ben Solomon TOGA 19/003 ASPiRATION - Prof Nick Pavlakis TOGA 16/005 OSCILLATE - Prof Ben Solomon TOGA 16/007 ALKTERNATE - Dr Malinda Itchins TOGA 16/009 ILLUMINATE - A/Prof Chee Lee
17:00 - 17:30	TOGA-Endorsed Clinical Trials	Chair: Dr Malinda Itchins TOGA 20/006 COGNITION Dr Maria Aslam TOGA 18/002 TROG 17.02 OUTRUN A/Prof Chee Lee TOGA 16/013 ANZ LCNF Activities and influence of the specialist lung cancer nurse Dr Vanessa Brunelli TOGA 21/001 CHEST-RT A/Prof Paul Mitchell TOGA 21/002 LUCAP Prof Fraser Brims TOGA 21/003 Lung cancer screening implementation Dr Nicole Rankin

Friday 23 July

Timing	Session	Speaker / Comments
7:15 - 8:00	Microsatellite Breakfast Symposium Topic TBD Sponsored by Bristol Myers Squibb	Debate: “Are two immunotherapies better than one in first line lung cancer treatment?” Chair: Prof Nick Pavlakis Negative: Dr Melissa Moore Medical Oncologist, St Vincent’s Hospital, Melbourne, Australia Affirmative: Prof Julie Brahmer Director of the Thoracic Oncology Program & Professor of Oncology, the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Maryland, USA Followed by perspectives from the audience
8:00 - 8:30	Light Refreshments Exhibition Booths open at 8:00am
8:30 - 9:30	Plenary Session	‘Gaps’ and inequalities in lung cancer care Chair: Mr Phillip Antippa “What is the lung cancer gap?” Ms Lillian Leigh Patient Research Advocate, Sydney, Australia “Implementation challenges when addressing inequalities” Dr Nicole Rankin Senior Research Fellow, Sydney School of Public Health Faculty of Medicine and Health, Sydney, Australia “The capacity of the health system to address inequalities” Prof Barbara McPake Director of Nossal Institute and Chair of Global Health, Melbourne School of Population and Global Health, Melbourne, Australia Panel: A/Prof Haryana Dhillon, Ms Abby Fyfe, Ms Alexandra Golledge, A/Prof Lou Irving
9:30 - 10:30	Practical tools for implementing best practice care and embedding research in lung cancer	Chair: Prof Shalini Vinod 1. Tissue banking in lung cancer – A/Prof Lucy Morgan 2. Lung cancer registry – Prof Fraser Brims 3. Teletrials – Dr Craig Underhill 4. Smoking Cessation – Prof Chris Paul
10:30 - 10:55	Morning Tea
10:55 - 11:40	Practical tools for implementing best practice care and embedding research in lung cancer (cont.)	Chair: Prof Shalini Vinod 5. Patient reported outcome measures – Dr Adeola Bamgboje-Ayodele 6. Funding lung cancer nurses – Ms Sara McLaughlin Barrett 7. RAPID program – Prof David Currow
11:40 - 12:00	Immunotherapy in Mesothelioma	Chair: Dr Steven Kao TOGA 18/001 DREAM3R Prof Anna Nowak Medical oncologist and Pro Vice Chancellor (Health and Medical Research), University of Western Australia, Perth
12:00 - 13:10	TOGA Scientific Committee Update	Chair: A/Prof Tom John Open to TOGA clinician and patient advocate members only TOGA working group research prioritisation and gap analysis New concepts for presentation
13:10 - 14:05	Lunch
14:05 - 14:35	TOGA Membership Meeting	Prof Nick Pavlakis Chair, TOGA Board of Directors TOGA Endorsement Policy - Prof Ben Solomon, Scientific Chair, TOGA Board of Directors
14:35 - 15:45	MDT Masterclass	Chairs: A/Prof Henry Marshall and Dr Steven Kao Speakers: Dr Venessa Chin, Dr Jonathan Williamson Panel: Dr Venessa Chin, Ms Helen Westman, A/Prof Michael Franco, Mr Michael Harden, A/Prof Lucy Morgan, Dr Diane Pascoe, Dr Tim Akhurst, Prof Wendy Cooper
15:45 - 16:00	Awards and Close
16:00 - 16:30	Afternoon Tea (to go)